Jeffrey Oram - 15 Oct 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role: Director
Signature: /s/ Jeffrey Oram
Issuer symbol: ALZN
Transactions as of: 15 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 18 Oct 2021, 17:00:46 UTC
Previous filing: 15 Sep 2021
Next filing: 16 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALZN	Common Stock	Options Exercise	$0	+47,222	+1700%	$0.000000	50,000	15 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALZN	Restricted Stock Grant	Options Exercise	$0	-47,222	-49%	$0.000000	50,000	15 Oct 2021	Common Stock	47,222		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the vesting of restricted stock
F2	Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
F3	The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021.